Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

    Journal of Hypertension Date published:

  • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

    The Lancet Date published:

  • Severe Hypoglycemia and Risks of Vascular Events and Death

    New England Journal of Medicine Date published:

  • Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis

    Intensive Care Medicine Date published:

  • Nature of association between severe hypoglycaemia and risks of vascular events and death in ADVANCE

    Date published:

  • Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor-Based Regimens

    Hypertension Date published:

  • Blood Pressure and Cardiovascular Disease: Tracing the Steps From Framingham

    Progress in Cardiovascular Diseases Date published:

  • The Framingham Study, Diabetes Mellitus and Cardiovascular Disease: Turning Back the Clock

    Progress in Cardiovascular Diseases Date published:

  • Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease

    European Heart Journal Date published:

  • THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE

    Date published:

  • Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial

    Journal of Hypertension Date published:

  • Does interleukin-18 or tumour necrosis factor-α have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand

    Cytokine Date published:

  • Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

    Journal of Hypertension Date published:

  • Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy

    Stroke Date published:

  • Responding to China's hypertensive crisis

    The Lancet Date published:

  • Risks of cardiovascular disease and severe hypoglycaemia according to cognitive function in people with type 2 diabetes in ADVANCE

    Date published: